Call for nominations, 2019 Seldin~Smith Award

The ASCI is pleased to call for nominations for the 2019 Donald Seldin~Holly Smith Award for Pioneering Research. The Award seeks to recognize and connect the next generation of physician-scientist leaders with the legacies of two of the ASCI’s most esteemed members, Drs. Donald W. Seldin and Lloyd H. “Holly” Smith Jr.

For the Award, the ASCI seeks nominations of outstanding physician-scientists who have demonstrated exceptional creativity and accomplishments in biomedical research. The ideal nominee:

  • is an early-stage, clinically active physician-scientist addressing fundamental questions that relate to human health and disease, and
  • shows great promise in biomedicine.

The recipient of the Seldin~Smith Award will receive an unrestricted grant of $30,000 to advance academic efforts. S/he will be recognized at the 2019 AAP/ASCI/APSA Joint Meeting, deliver a research talk at the 2020 Joint Meeting, and receive mentoring from the members of the Seldin~Smith Award Selection Committee and Advisory Committee.

Eligibility

  • MD (or the equivalent) or MD/PhD;
  • The candidate should be more than 2 years but not more than 6 years from first faculty (or the equivalent) appointment at the time of acceptance in April 2019;
  • The candidate spends substantial time in research while providing direct patient care.

This competition is not restricted to any geographic location.

Application

Physician-scientists should apply directly by sending nominations by email attachments to staff@the-asci.org.

  • Completed nomination form, including:
    • a summary of the nominee’s research (not to exceed 100 words)
    • a description of the nominee’s most significant achievement (not to exceed 500 words).
    • a list of the nominee’s three most significant publications and a short statement describing the significance of each publication (not to exceed 100 words each).
    • Nominee’s agreement, if chosen as the recipient, to attend the 2019 AAP/ASCI/APSA Joint Meeting (April 5-7) and the 2020 AAP/ASCI/APSA Joint Meeting (April 3-5).
  • PDFs of the nominee’s three most significant publications as listed in the nomination form.
  • Nominee’s curriculum vitae. Include only educational background, major awards, and peer-reviewed publications (do not include abstracts, grants, or meeting presentations).
  • No more than two letters of support (as PDFs), one from the nominee’s primary mentor, the other ideally from an individual who is a recognized expert on the subject of the nominee’s research.

Notable dates and selection process

  • Nomination deadline: October 29, 2018.
  • Recipient will be notified by early 2019.
  • Recipient will be recognized at the 2019 AAP/ASCI/APSA Joint Meeting, April 5-7.
  • Recipient will deliver a research talk at the 2020 AAP/ASCI/APSA Joint Meeting, April 3-5.

The Seldin~Smith Award Selection Committee reviews nominations and selects finalists for further consideration. Finalists are reviewed by the Seldin~Smith Award Advisory Committee.

About the ASCI

Founded in 1908, the ASCI is home to physician-scientist leaders in academic medicine and industry across the world. The ASCI seeks to support the scientific efforts, educational needs, and clinical aspirations of physician-scientists to improve human health. The Society, based in the United States, is a nonprofit 501(c)(3) organization.

Call for nominations, 2019 Stanley J. Korsmeyer Award

Nominations for the ASCI’s 2019 Stanley J. Korsmeyer Award are now open. The recognition, first called the ASCI Award, was renamed in 2006 in honor of Dr. Korsmeyer, the first recipient of the Award in 1998, who passed away in 2005. The Korsmeyer Award recognizes individuals for their advancement of knowledge in a specific field and mentoring of future generations of life science researchers. Information on all past honorees is available here.

Nominees for the Stanley J. Korsmeyer Award must be ASCI members who are 55 years of age or younger as of January 1, 2019. They shall have made significant contributions to biomedical science and shall have adhered to the principles of scientific excellence that the ASCI exemplifies. The nominee should have a record that reflects high standards of intellectual integrity, a deep and abiding respect for the community of biomedical scientists, and a strong commitment to mentoring the next generation of physician-scientists. Prior nominees may be re-nominated. However, current ASCI Council members and prior Award recipients may not be nominated.

Nominations consist of:

  • a summary of the nominee’s accomplishments (in plain text, not to exceed 250 words),
  • a brief NIH biosketch (as a PDF),
  • a full curriculum vitae, including all publications and invited lectures (as a PDF),
  • and a trainee table (preferred as a PDF).

Nominations must be submitted by ASCI members through their online accounts.

The deadline for nominations is October 11, 2018, at 11:59 PM Eastern (extended from October 8).

Call for applications, JCI Insight Editor, 2019-2024

The American Society for Clinical Investigation (ASCI) seeks an Editor in Chief to lead JCI Insight. The journal was launched in 2016 to support the ASCI’s mission of publishing impactful biomedical research, along with the Journal of Clinical Investigation (JCI).

About the Journal

JCI Insight is a peer-reviewed journal dedicated to the publication of research in all biomedical specialties, ranging from preclinical to clinical studies. While JCI Insight is complementary to the JCI, and both journals are governed by ASCI policies, the Editors and their boards are independent. JCI Insight draws submissions directly and considers submissions previously evaluated by the JCI and other journals. The journal, which the ASCI self-publishes along with the JCI, is online only and freely available to all readers and is supported by publication fees.

Duties of the Editor

The Editor is responsible for: determining the scientific content of JCI Insight; ensuring the quality and integrity of publications; assembling and leading an editorial board to handle research submissions; and meeting goals set by the ASCI Council and Publications Committee.

The selected candidate will have responsibilities that include service on the Council. The term of office is 5 years and begins September 2019.

Eligibility of the Editor and Editorial Board

To be considered for the position of Editor, a candidate must:

  • be a member of the ASCI
  • demonstrate a strong scientific track record

For the proposed Editorial Board:

  • At least two-thirds of the proposed board must be ASCI members (active or senior) in good standing
  • Multi-institution applications are encouraged

Application timeline

  • October 31, 2018: Letters of intent (LOI) due. Applicants submitting LOI will receive an operational overview of the ASCI and JCI Insight for use in developing full applications.
  • January 10, 2019: Full applications due.
  • March 4, 2019: Finalists for the Editor position determined.
  • April 4, 2019: Editor Selection Committee interviews finalists in Chicago.

Full application requirements

The applicant should address the following areas in 5 or fewer single-spaced pages:

  • Describe your vision for the scientific scope of manuscripts published in the journal under your leadership, including scientific areas you see as priorities for JCI Insight and areas you see as opportunities for growth.
  • Provide details of any proposed editorial board members. Describe how you will ensure that the team has the breadth to handle submissions across all specialties and ranging from basic research to clinical trials and bioinformatics.
  • Describe how the proposed board will evaluate manuscripts and specific efforts to ensure scientific rigor, fair decisions, and timeliness. Additionally, comment on the criteria your board will use to select suitable articles to invite for transfer from the JCI to JCI Insight.
  • Describe how you will ensure that JCI Insight complements rather than competes with the JCI in the ASCI family of journals.
  • In the event that you cannot complete the duration of the term, describe the process by which a candidate to replace the Editor would be identified (subject to approval by the Council and a vote by the membership).

In addition, the application must include a letter from each proposed Board member stating a commitment to the role.

Submitting letters of intent and applications

Address materials to Kieren Marr, MD, Chair, Editor Selection Committee, and send as an attachment to staff@the-asci.org.

Questions

Contact Sarah Jackson, Executive Editor, at sarah.jackson@insight.jci.org.

Review of applications

An Editor Selection Committee will review applications, interview candidates, and recommend a selection to the ASCI Council, which then submits the recommendation to a vote of the Active segment of the ASCI membership.

Editor Selection Committee

Chair

Kieren Marr, MD
Johns Hopkins University School of Medicine

Members

Rexford S. Ahima, MD, PhD
Johns Hopkins University School of Medicine

Hossein Ardehali, MD, PhD
Northwestern University Feinberg School of Medicine

Serpil C. Erzurum, MD
Cleveland Clinic

Andrew P. Fontenot, MD
University of Colorado School of Medicine

Sarah Jackson, PhD (non-voting)
Executive Editor

Chaim Putterman, MD
Albert Einstein College of Medicine of Yeshiva University

W. Kimryn Rathmell, MD, PhD
Vanderbilt University School of Medicine

Howard A. Rockman, MD
Duke University School of Medicine

Vijay Shah, MD
Mayo Clinic

Lorraine B. Ware, MD
Vanderbilt University School of Medicine